1. Home
  2. CNXC vs FOLD Comparison

CNXC vs FOLD Comparison

Compare CNXC & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CNXC
  • FOLD
  • Stock Information
  • Founded
  • CNXC 1991
  • FOLD 2002
  • Country
  • CNXC United States
  • FOLD United States
  • Employees
  • CNXC N/A
  • FOLD N/A
  • Industry
  • CNXC Computer Software: Prepackaged Software
  • FOLD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CNXC Technology
  • FOLD Health Care
  • Exchange
  • CNXC Nasdaq
  • FOLD Nasdaq
  • Market Cap
  • CNXC 3.2B
  • FOLD 2.9B
  • IPO Year
  • CNXC N/A
  • FOLD 2007
  • Fundamental
  • Price
  • CNXC $45.17
  • FOLD $9.19
  • Analyst Decision
  • CNXC Buy
  • FOLD Strong Buy
  • Analyst Count
  • CNXC 5
  • FOLD 9
  • Target Price
  • CNXC $75.00
  • FOLD $17.00
  • AVG Volume (30 Days)
  • CNXC 751.3K
  • FOLD 2.2M
  • Earning Date
  • CNXC 03-25-2025
  • FOLD 02-19-2025
  • Dividend Yield
  • CNXC 2.95%
  • FOLD N/A
  • EPS Growth
  • CNXC N/A
  • FOLD N/A
  • EPS
  • CNXC 3.71
  • FOLD N/A
  • Revenue
  • CNXC $9,618,900,000.00
  • FOLD $528,294,999.00
  • Revenue This Year
  • CNXC $1.29
  • FOLD $34.88
  • Revenue Next Year
  • CNXC $2.04
  • FOLD $20.78
  • P/E Ratio
  • CNXC $12.16
  • FOLD N/A
  • Revenue Growth
  • CNXC 35.20
  • FOLD 32.29
  • 52 Week Low
  • CNXC $36.28
  • FOLD $8.79
  • 52 Week High
  • CNXC $84.11
  • FOLD $14.02
  • Technical
  • Relative Strength Index (RSI)
  • CNXC 37.31
  • FOLD 38.52
  • Support Level
  • CNXC $44.39
  • FOLD $9.32
  • Resistance Level
  • CNXC $49.71
  • FOLD $10.00
  • Average True Range (ATR)
  • CNXC 1.71
  • FOLD 0.33
  • MACD
  • CNXC -0.62
  • FOLD -0.05
  • Stochastic Oscillator
  • CNXC 12.56
  • FOLD 17.35

About CNXC Concentrix Corporation

Concentrix Corp is a technology enabled company specialized in customer engagement and customer management. The company provides end-to-end capabilities, including CX process optimization, technology innovation and design engineering, front- and back-office automation, analytics and business transformation services to clients in five industry verticals. The Company's verticals are technology and consumer electronics, retail, travel and e-commerce, communications and media, banking, financial services and insurance, and healthcare. Geographically, the company operates in Philippines, Unites States, India, Frances and Others. Maximum revenue is from Technology and consumer electronics industry and geographically from USA.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: